197 related articles for article (PubMed ID: 30499686)
1. Antibiotic-nanomedicines: facing the challenge of effective treatment of antibiotic-resistant respiratory tract infections.
Ritsema JA; der Weide HV; Te Welscher YM; Goessens WH; van Nostrum CF; Storm G; Bakker-Woudenberg IA; Hays JP
Future Microbiol; 2018 Nov; 13():1683-1692. PubMed ID: 30499686
[TBL] [Abstract][Full Text] [Related]
2. A New Era of Pulmonary Delivery of Nano-antimicrobial Therapeutics to Treat Chronic Pulmonary Infections.
Merchant Z; Buckton G; Taylor KM; Stapleton P; Saleem IY; Zariwala MG; Somavarapu S
Curr Pharm Des; 2016; 22(17):2577-98. PubMed ID: 26983671
[TBL] [Abstract][Full Text] [Related]
3. Local treatment of respiratory infections with antibiotics.
Stout SA; Derendorf H
Drug Intell Clin Pharm; 1987 Apr; 21(4):322-9. PubMed ID: 3552545
[TBL] [Abstract][Full Text] [Related]
4. Aerosol administration of antibiotics.
Smith AL; Ramsey B
Pediatr Pulmonol Suppl; 1995; 11():68-9. PubMed ID: 7547353
[TBL] [Abstract][Full Text] [Related]
5. Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis.
Falagas ME; Kasiakou SK
Infection; 2007 Feb; 35(1):3-10. PubMed ID: 17297582
[TBL] [Abstract][Full Text] [Related]
6. Inhalable Levofloxacin Liposomes Complemented with Lysozyme for Treatment of Pulmonary Infection in Rats: Effective Antimicrobial and Antibiofilm Strategy.
Gupta PV; Nirwane AM; Nagarsenker MS
AAPS PharmSciTech; 2018 Apr; 19(3):1454-1467. PubMed ID: 29464594
[TBL] [Abstract][Full Text] [Related]
7. Inhaled formulations and pulmonary drug delivery systems for respiratory infections.
Zhou QT; Leung SS; Tang P; Parumasivam T; Loh ZH; Chan HK
Adv Drug Deliv Rev; 2015 May; 85():83-99. PubMed ID: 25451137
[TBL] [Abstract][Full Text] [Related]
8. Novel amikacin inhaled formulation for the treatment of lower respiratory tract infections.
Antoniu S; Azoicai D
Drugs Today (Barc); 2013 Nov; 49(11):683-92. PubMed ID: 24308015
[TBL] [Abstract][Full Text] [Related]
9. Rational use of antibiotics to treat respiratory tract infections.
File TM; Hadley JA
Am J Manag Care; 2002 Aug; 8(8):713-27. PubMed ID: 12212759
[TBL] [Abstract][Full Text] [Related]
10. Parenteral antibiotic therapy in the treatment of lower respiratory tract infections. Strategies to minimize the development of antibiotic resistance.
Cazzola M; Matera MG; Noschese P
Pulm Pharmacol Ther; 2000; 13(6):249-56. PubMed ID: 11061979
[TBL] [Abstract][Full Text] [Related]
11. Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections.
Momin MAM; Tucker IG; Doyle CS; Denman JA; Sinha S; Das SC
Int J Pharm; 2018 Apr; 541(1-2):26-36. PubMed ID: 29458207
[TBL] [Abstract][Full Text] [Related]
12. Inhaled antimicrobial therapy - barriers to effective treatment.
Weers J
Adv Drug Deliv Rev; 2015 May; 85():24-43. PubMed ID: 25193067
[TBL] [Abstract][Full Text] [Related]
13. [Designs of optimized microbial therapy systems of respiratory infections].
Morimoto K
Yakugaku Zasshi; 2013; 133(1):81-92. PubMed ID: 23292024
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic prescriptions associated with outpatient visits for acute upper respiratory tract infections among adult Medicaid recipients in North Carolina.
Brown DW; Taylor R; Rogers A; Weiser R; Kelley M
N C Med J; 2003; 64(4):148-56. PubMed ID: 12971239
[TBL] [Abstract][Full Text] [Related]
15. Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy.
Dagan R; Klugman KP; Craig WA; Baquero F
J Antimicrob Chemother; 2001 Feb; 47(2):129-40. PubMed ID: 11157895
[TBL] [Abstract][Full Text] [Related]
16. [Antibiotic resistance in respiratory tract infections: what can we do?].
Flückiger U
Praxis (Bern 1994); 2001 May; 90(21):931-4. PubMed ID: 11441707
[TBL] [Abstract][Full Text] [Related]
17. Children with respiratory tract infections in Swedish primary care; prevalence of antibiotic resistance in common respiratory tract pathogens and relation to antibiotic consumption.
Tyrstrup M; Melander E; Hedin K; Beckman A; Mölstad S
BMC Infect Dis; 2017 Sep; 17(1):603. PubMed ID: 28870173
[TBL] [Abstract][Full Text] [Related]
18. New therapeutic options for respiratory tract infections.
Bassetti M; Righi E; Carnelutti A
Curr Opin Infect Dis; 2016 Apr; 29(2):178-86. PubMed ID: 26871402
[TBL] [Abstract][Full Text] [Related]
19. Inhaled antibiotics for lower respiratory tract infections: focus on ciprofloxacin.
Serisier DJ
Drugs Today (Barc); 2012 May; 48(5):339-51. PubMed ID: 22645722
[TBL] [Abstract][Full Text] [Related]
20. Isolation of an amikacin-resistant Escherichia coli strain after tobramycin treatment of previous recurrent episodes of respiratory tract infections caused by Pseudomonas aeruginosa.
Ruiz J; Bertran S; Sauca G; Julià A; Vila X; Gómez E; Jiménez de Anta MT; Vila J
Clin Microbiol Infect; 2005 Jan; 11(1):71-3. PubMed ID: 15649309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
